The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment

JAMA. 2017 May 16;317(19):1949-1950. doi: 10.1001/jama.2017.4413.
No abstract available

MeSH terms

  • Advisory Committees*
  • Age Factors
  • Aged
  • Black People
  • Black or African American
  • Decision Making*
  • Erectile Dysfunction / etiology
  • False Positive Reactions
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Medical Overuse
  • Middle Aged
  • Neoplasm Metastasis / prevention & control
  • Patient Preference*
  • Practice Guidelines as Topic / standards*
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / therapy
  • Risk Assessment*
  • United States
  • Urinary Incontinence / etiology
  • Watchful Waiting

Substances

  • Prostate-Specific Antigen